{"database": "lobbying", "table": "lobbying_activities", "rows": [[489532, "b4e7dfec-c7c7-4088-9b36-e995b04e00cc", "YY", "SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.", 34502, "SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C", 2006, "year_end", "HCR", "Legislation regarding pandemic vaccine production:  H.R.3970, Bioterror Pandemic Preparedness Protection Act; H.R.4062, Pandemic Preparedness Response Act; H.R.4603, Pandemic Seasonal Influenza Act of 2005; S.1437, Bioterror Pandemic Preparedness Protection Act;S.1821, Pandemic Preparedness Response Act; S.1873, Biodefense Pandemic Vaccine Drug Development Act of 2005; S.1880, National Biodefense Pandemic Preparedness Act of 2005.\r\nPreserve Access to Affordable Drugs Act of 2005; S.873, Medicare Prescription drug Savings and Choice Act of 2005; S.930, Food and Drug Administration Safety Act of 2005.\n\nLegislation controlling access to precursor chemicals for meth production and/or combating meth:  H.R.1056, Methamphetamine Precursor Control Act of 2005; H.R.13, Clean, Learn, Educate, Abolish, Neutralize, and Undermine Production (CLEAN-UP) of Methamphetamine Act; H.R.1350, Methamphetamine Blister Pack Loophole Elimination Act of 2005; H.R.2335, Meth-Endangered Children Protection Act of 2005; H.R.313, Exile Meth Act; H.R.314, Combat Meth Act of 2005; H.R.3199, Patient Act H.R.1572, Preserving Access to Affordable Drugs Act of 2005; H.R.1626, Medicare Prescription Drug Improvement Act; H.R.1669, Pharmacy Benefit Manager Transparency Act of 2005; H.R.328, Pharmaceutical Market Access Act of 2005; H.R.417, Medical Innovation Prize Act of 2005; H.R.4660, Requiring Emergency Pharmaceutical Access for Individual Relief (REPAIR) Act of 2006; H.R.4663, Authorize the Secretary of HHS to Reimburse States for Expenditures Associated with the Implementation of the Medicare Prescription Drug Benefit for Dual Eligible Individuals; H.R.4665, Amend Title XIX of the Social Security Act to Provide for an Offset from the Medicaid Clawback for State Emergency Prescription Drug Expenditures for Medicare Dual-Eligible Individuals; H.R.4675, Medicare State Reimbursement Act of 2006; H.R.4685, Medicare Prescription Drug Emergency Guarantee Act of 2006; H.R.4715, Amend Title XVIII of the Social Secruity Act to Estend the 2006 Annual Coordinated Election Period for Medicare Prescription Drug Plans through August 15, 2006; H.R.4719, Patients Before Profits Act of 2006; H.R.4721, Require Secretary of HHS To Provide Federal Medicaid for State Costs Associated with Ensuring Access to Prescription Drug Benefits to Part D Eligible Individuals; H.R.700, Pharmaceutical Market Access and Drug Safety Act of 2005; H.R.752, Medicare Prescription Drug Savings and Choice Act of 2005; H.R.870, Pharmaceutical research and Manufacturers Accountability Act of 2005, PhRMA Act of 2005; S.109, Pharmaceutical Market Access Act of 2005; S.1128, Pharmaceutical Advertising and Prudent Purchasing Act; S.334, Pharmaceutical Market Access and Drug Safety Act of 2005; S.354, HEALTH Act of 2005, Health Efficient, Accessible, Low-Cost, timely Healthcare Act of 2005; S.764, Preserve Access to Affordable Drugs Act of 2005; S.873, Medicare Prescription drug Savings and Choice Act of 2005; S.930, Food and Drug Administration Safety Act of 2005.\n\r\nMethamphetamine Precursor Control Act of 2005; H.R.13, Clean, Learn, Educate, Abolish, Neutralize, and Undermine Production (CLEAN-UP) of Methamphetamine Act; H.R.1350, Methamphetamine Blister Pack Loophole Elimination Act of 2005; H.R.152, Preserving Access to Affordable Drugs Act of 2005; H.R.1572, Preserving Access to Affordable Drugs Act of 2005; H.R.1626, Medicare Prescription Drug Improvement Act; H.R.1669, Pharmacy Benefit Manager Transparency Act of 2005; H.R.2335, Meth-Endangered Children Protection Act of 2005; H.R.313, Exile Meth Act; H.R.314, Combat Meth Act of 2005; H.R.3199, Patient Act Reauthorization; H.R.328, Pharmaceutical Market Access Act of 2005; H.R.3324, Arrest Methamphetamine Act of 2005; H.R.3889, The Methamphetamine Elimination Act; H.R.3970, Bioterror Pandemic Preparedness Protection Act; H.R.4062, Pandemic Preparedness Response Act; H.R.4603, Pandemic Seasonal Influenza Act of 2005; H.R.4660, Requiring Emergency Pharmaceutical Access for Individual Relief (REPAIR) Act of 2006; H.R.4663, Authorize the Secretary of HHS to Reimburse States for Expenditures Associated with the Implementation of the Medicare Prescription Drug Benefit for Dual Eligible Individuals; H.R.4665, Amend Title XIX of the Social Security Act to Provide for an Offset from the Medicaid Clawback for State Emergency Prescription Drug Expenditures for Medicare Dual-Eligible Individuals; H.R.4675, Medicare State Reimbursement Act of 2006; H.R.4685, Medicare Prescription Drug Emergency Guarantee Act of 2006; H.R.4715, Amend Title XVIII of the Social Secruity Act to Estend the 2006 Annual Coordinated Election Period for Medicare Prescription Drug Plans through August 15, 2006; H.R.4719, Patients Before Profits Act of 2006; H.R.4721, Require Secretary of HHS To Provide Federal Medicaid for State Costs Associated with Ensuring Access to Prescription Drug Benefits to Part D Eligible Individuals; H.R.700, Pharmaceutical Market Access and Drug Safety Act of 2005; H.R.417, Medical Innovation Prize Act of 2005; H.R.752, Medicare Prescription Drug Savings and Choice Act of 2005; H.R.798, Methamphetamine Remediation Act of 2005; H.R.870, Pharmaceutical research and Manufacturers Accountability Act of 2005, PhRMA Act of 2005; S.103, Combat Meth Act of 2005; S.109, Pharmaceutical Market Access Act of 2005; S.1128, Pharmaceutical Advertising and Prudent Purchasing Act; S.1361, A bill to amend the Controlled Substances Act to treat drug offenses involving crystal meth similarly to drug offenses involving crack cocaine; S.1437, Bioterror Pandemic Preparedness Protection Act; S.1821, Pandemic Preparedness Response Act; S.1873, Biodefense Pandemic Vaccine Drug Development Act of 2005; S.1880, National Biodefense Pandemic Preparedness Act of 2005; S.334, Pharmaceutical Market Access and Drug Safety Act of 2005; S.354, HEALTH Act of 2005, Health Efficient, Accessible, Low-Cost, timely Healthcare Act of 2005; S.764,\r\nH.CON.RES.75, Expressing the sense of the congress that the illegal importation of prescription drugs severely undermines the regulatory protections afforded to the United States consumers, and for other purposes; H.R.1056,", "HOUSE OF REPRESENTATIVES,SENATE", null, 820000, 0, 0, "2007-02-14T14:11:41-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["489532"], "units": {}, "query_ms": 1.0292429942637682, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}